INVESTMENT IN TNF PHARMACEUTICALS, INC. (Tables)

9 Months Ended

Jan. 31, 2025


Balance of Series G Preferred Stock as of April 30, 2024	$	–
Purchased		17,410,050
Change in fair value		(1,642,050	)
Balance of Series G Preferred Stock as of January 31, 2025	$	15,768,000

Below is a summary of activity for the Preferred Stock Warrants as of January 31, 2025:


Balance of Warrant assets as of April 30, 2024	$	–
Purchased		10,985,684
Change in fair value		(8,123,684	)
Balance of Warrant assets as of January 31, 2025	$	2,862,000